Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2014, Article ID 819362, 11 pages
http://dx.doi.org/10.1155/2014/819362
Review Article

Detection of Circulating Tumor Cells

Department of Medical Cell BioPhysics, Faculty of Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Carre, Room C4437, Hallenweg 23, 7522 NH Enschede, The Netherlands

Received 2 March 2014; Accepted 17 May 2014; Published 15 July 2014

Academic Editor: Hiroki Yoshida

Copyright © 2014 Sanne de Wit et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. R. Ashworth, “A case of cancer in which cells similar to those in the tumours were seen in the blood after death,” Australasian Medical Journal, vol. 14, pp. 146–147, 1869. View at Google Scholar
  2. I. J. Fidler, “The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited,” Nature Reviews Cancer, vol. 3, no. 6, pp. 453–458, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. W. J. Allard, J. Matera, M. C. Miller et al., “Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases,” Clinical Cancer Research, vol. 10, no. 20, pp. 6897–6904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Cristofanilli, G. T. Budd, M. J. Ellis et al., “Circulating tumor cells, disease progression, and survival in metastatic breast cancer,” The New England Journal of Medicine, vol. 351, no. 8, pp. 781–791, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Cristofanilli, D. F. Hayes, G. T. Budd et al., “Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer,” Journal of Clinical Oncology, vol. 23, no. 7, pp. 1420–1430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. D. F. Hayes, M. Cristofanilli, G. T. Budd et al., “Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival,” Clinical Cancer Research, vol. 12, no. 14, pp. 4218–4224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. T. Budd, M. Cristofanilli, M. J. Ellis et al., “Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer,” Clinical Cancer Research, vol. 12, no. 21, pp. 6403–6409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. J. Cohen, C. J. A. Punt, N. Iannotti et al., “Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer,” Journal of Clinical Oncology, vol. 26, no. 19, pp. 3213–3221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. J. Cohen, C. J. A. Punt, N. Iannotti et al., “Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer,” Annals of Oncology, vol. 20, no. 7, pp. 1223–1229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. S. de Bono, H. I. Scher, R. B. Montgomery et al., “Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer,” Clinical Cancer Research, vol. 14, no. 19, pp. 6302–6309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. G. Krebs, J. Hou, R. Sloane et al., “Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches,” Journal of Thoracic Oncology, vol. 7, no. 2, pp. 306–315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. J. N. Hiltermann, M. M. Pore, A. van den Berg et al., “Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor,” Annals of Oncology, vol. 23, no. 11, Article ID mds138, pp. 2937–2942, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Hiraiwa, H. Takeuchi, H. Hasegawa et al., “Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers,” Annals of Surgical Oncology, vol. 15, no. 11, pp. 3092–3100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Kurihara, T. Itoi, A. Sofuni et al., “Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 15, no. 2, pp. 189–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Poveda, S. B. Kaye, R. McCormack et al., “Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer,” Gynecologic Oncology, vol. 122, no. 3, pp. 567–572, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Rink, F. K. H. Chun, S. Minner et al., “Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer,” BJU International, vol. 107, no. 10, pp. 1668–1675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Gazzaniga, A. Gradilone, E. de berardinis et al., “Prognostic value of circulating tumor cellsin nonmuscle invasive bladder cancer: a cell search analysis,” Annals of Oncology, vol. 23, no. 9, Article ID mdr619, pp. 2352–2356, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Naoe, Y. Ogawa, J. Morita et al., “Detection of circulating urothelial cancer cells in the blood using the CellSearch system,” Cancer, vol. 109, no. 7, pp. 1439–1445, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. H. Strijbos, J. W. Gratama, P. I. M. Schmitz et al., “Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel,” European Journal of Cancer, vol. 46, pp. 2027–2035, 2010. View at Google Scholar
  20. J. L. Rowand, G. Martin, G. V. Doyle et al., “Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas,” Cytometry A, vol. 71, no. 2, pp. 105–113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Damani, A. Bacconi, O. Libiger et al., “Characterization of circulating endothelial cells in acute myocardial infarction,” Science Translational Medicine, vol. 4, no. 126, Article ID 126ra33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Rao, T. Bui, M. Connelly et al., “Circulating melanoma cells and survival in metastatic melanoma,” International Journal of Oncology, vol. 38, no. 3, pp. 755–760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. B. Smerage, G. T. Budd, G. V. Doyle et al., “Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer,” Molecular Oncology, vol. 7, no. 3, pp. 680–692, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. T. Ligthart, F.-C. Bidard, C. Decraene et al., “Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer,” Annals of Oncology, vol. 24, no. 5, Article ID mds625, pp. 1231–1238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. F. Swennenhuis, A. G. J. Tibbe, R. Levink, R. C. J. Sipkema, and L. W. M. M. Terstappen, “Characterization of circulating tumor cells by fluorescence in situ hybridization,” Cytometry Part A, vol. 75, no. 6, pp. 520–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Attard, J. F. Swennenhuis, D. Olmos et al., “Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer,” Cancer Research, vol. 69, no. 7, pp. 2912–2918, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. S. De Bono, G. Attard, A. Adjei et al., “Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor,” Clinical Cancer Research, vol. 13, no. 12, pp. 3611–3616, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. American Cancer Society, Cancer Facts & Figures 2013, American Cancer Society, 2013.
  29. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, and P. Boyle, “Estimates of the cancer incidence and mortality in Europe in 2006,” Annals of Oncology, vol. 18, no. 3, pp. 581–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. F. A. W. Coumans, S. Siesling, and L. W. M. M. Terstappen, “Detection of cancer before distant metastasis,” BMC Cancer, vol. 13, article 283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. C. G. Rao, D. Chianese, G. V. Doyle et al., “Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.,” International journal of oncology, vol. 27, no. 1, pp. 49–57, 2005. View at Google Scholar · View at Scopus
  32. L. Terstappen, C. Rao, and P. Liberti, “Increased separation efficiency via controlled aggregation of magnetic nanoparticles,” US patent 6,551,843 B1, 2003.
  33. D. A. Smirnov, D. R. Zweitzig, B. W. Foulk et al., “Global gene expression profiling of circulating tumor cells,” Cancer Research, vol. 65, no. 12, pp. 4993–4997, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. F. Swennenhuis, J. Reumers, K. Thys, J. Aerssens, and L. W. Terstappen, “Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS,” Genome Medicine, vol. 5, no. 11, article 106, 2013. View at Google Scholar
  35. C. J. Larson, J. G. Moreno, K. J. Pienta et al., “Apoptosis of circulating tumor cells in prostate cancer patients,” Cytometry A, vol. 62, no. 1, pp. 46–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. F. A. W. Coumans, C. J. M. Doggen, G. Attard, J. S. de Bono, and L. W. M. M. Terstappen, “All circulating EpCAM+CK+CD45-objects predict overall survival in castration-resistant prostate cancer,” Annals of Oncology, vol. 21, no. 9, pp. 1851–1857, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. G. J. Tibbe, M. C. Miller, and L. W. M. M. Terstappen, “Statistical considerations for enumeration of circulating tumor cells,” Cytometry Part A, vol. 71, no. 3, pp. 154–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Kraan, S. Sleijfer, M. H. Strijbos et al., “External quality assurance of circulating tumor cell enumeration using the CellSearch system: a feasibility study,” Cytometry B: Clinical Cytometry, vol. 80, no. 2, pp. 112–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. T. Ligthart, F. A. W. Coumans, G. Attard, A. M. Cassidy, J. S. de Bono, and L. W. M. M. Terstappen, “Unbiased and automated identification of a circulating tumour cell definition that associates with overall survival,” PLoS ONE, vol. 6, no. 11, Article ID e27419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. T. Ligthart, F. A. W. Coumans, F. Bidard et al., “Circulating tumor cells count and morphological features in breast, colorectal and prostate cancer,” PLoS ONE, vol. 8, no. 6, Article ID e67148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Racila, D. Euhus, A. J. Weiss et al., “Detection and characterization of carcinoma cells in the blood,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 8, pp. 4589–4594, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. L. W. Terstappen, C. Rao, S. Gross, and A. J. Weiss, “Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast,” International Journal of Oncology, vol. 17, no. 3, pp. 573–578, 2000. View at Google Scholar · View at Scopus
  43. S. Meng, D. Tripathy, S. Shete et al., “HER-2 gene amplification can be acquired as breast cancer progresses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 25, pp. 9393–9398, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Meng, D. Tripathy, S. Shete et al., “uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17361–17365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. D. F. Hayes, T. M. Walker, B. Singh et al., “Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer,” International Journal of Oncology, vol. 21, no. 5, pp. 1111–1117, 2002. View at Google Scholar · View at Scopus
  46. F. A. W. Coumans, S. T. Ligthart, J. W. Uhr, and L. W. M. M. Terstappen, “Challenges in the enumeration and phenotyping of CTC,” Clinical Cancer Research, vol. 18, no. 20, pp. 5711–5718, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. F. Jiang, M. Cristofanilli, Z. M. Shao et al., “Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial,” Annals of Oncology, vol. 24, pp. 2766–2772, 2013. View at Publisher · View at Google Scholar
  48. M. Thalgott, B. Rack, T. Maurer et al., “Detection of circulating tumor cells in different stages of prostate cancer,” Journal of Cancer Research and Clinical Oncology, vol. 139, no. 5, pp. 755–763, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Resel Folkersma, L. San José Manso, I. Galante Romo, J. Moreno Sierra, and C. Olivier Gómez, “Prognostic significance of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer,” Urology, vol. 80, no. 6, pp. 1328–1332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Okegawa, K. Hayashi, H. Hara, K. Nutahara, and E. Higashihara, “Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer: Original article: Clinical investigation,” International Journal of Urology, vol. 17, no. 3, pp. 254–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. D. J. Gallagher, M. I. Milowsky, N. Ishill et al., “Detection of circulating tumor cells in patients with urothelial cancer,” Annals of Oncology, vol. 20, no. 2, pp. 305–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Liu, Q. Liu, T. Wang et al., “Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker,” BMC Cancer, vol. 13, article 202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Farace, C. Massard, N. Vimond et al., “A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas,” British Journal of Cancer, vol. 105, no. 6, pp. 847–853, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. J.-Y. Pierga, F.-C. Bidard, C. Cropet et al., “Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial,” Annals of Oncology, vol. 24, no. 12, pp. 2999–3004, 2013. View at Google Scholar
  55. K. Tryfonidis, I. Boukovinas, N. Xenidis et al., “A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer,” Breast, vol. 22, no. 6, pp. 1171–1177, 2013. View at Publisher · View at Google Scholar
  56. B. Mostert, Y. Jiang, A. M. Sieuwerts et al., “KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue,” International Journal of Cancer, vol. 133, no. 1, pp. 130–141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. JT. Kaifi, M. Kunkel, J. Zhu, DT. Dicker, NJ. Gusani, and Z. Yang, “Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients,” Cancer Biology & Therapy, vol. 14, no. 12, pp. 1174–1181, 2013. View at Publisher · View at Google Scholar
  58. Y. Kuboki, S. Matsusaka, S. Minowa et al., “Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer,” Anticancer Research, vol. 33, no. 9, pp. 3905–3910, 2013. View at Google Scholar
  59. J. Sastre, M. Vidaurreta, A. Gómez et al., “Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab,” Clinical Colorectal Cancer, vol. 12, pp. 280–286, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. O. Juan, J. Vidal, R. Gisbert, J. Muñoz, S. Maciá, and J. Gómez-Codina, “Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine,” Clinical & Translational Oncology, vol. 16, pp. 637–643, 2014. View at Publisher · View at Google Scholar
  61. M. G. Krebs, R. Sloane, L. Priest et al., “Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 29, no. 12, pp. 1556–1563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Naito, F. Tanaka, A. Ono et al., “Prognostic impact of circulating tumor cells in patients with small cell lung cancer,” Journal of Thoracic Oncology, vol. 7, no. 3, pp. 512–519, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Khoja, A. Backen, R. Sloane et al., “A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker,” British Journal of Cancer, vol. 106, no. 3, pp. 508–516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. M. S. Khan, T. Tsigani, M. Rashid et al., “Circulating tumor cells and EpCAM expression in neuroendocrine tumors,” Clinical Cancer Research, vol. 17, no. 2, pp. 337–345, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. R. J. Amato, V. Melnikova, Y. Zhang et al., “Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer,” Urology, vol. 81, no. 6, pp. 1303–1307, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. M. J. M. Magbanua, E. V. Sosa, J. H. Scott et al., “Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer,” BMC Cancer, vol. 12, article 78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. F. A. W. Coumans, S. T. Ligthart, and L. W. M. M. Terstappen, “Interpretation of changes in circulating tumor cell counts,” Translational Oncology, vol. 5, no. 6, pp. 486–491, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. H. W. Hou, M. E. Warkiani, B. L. Khoo et al., “Isolation and retrieval of circulating tumor cells using centrifugal forces,” Scientific Reports, vol. 3, article 1259, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Ozkumur, A. M. Shah, J. C. Ciciliano et al., “Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells,” Science Translational Medicine, vol. 5, no. 179, Article ID 179ra47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Choi, K. B. Kim, C. S. Jeon et al., “A label-free DC impedance-based microcytometer for circulating rare cancer cell counting,” Lab on a Chip, vol. 13, no. 5, pp. 970–977, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. F. A. W. Coumans, G. van Dalum, M. Beck, and L. W. M. M. Terstappen, “Filter characteristics influencing circulating tumor cell enrichment from whole blood,” PLoS ONE, vol. 8, no. 4, Article ID e61770, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. T. J. Park, S. J. Lee, D. K. Kim, N. S. Heo, J. Y. Park, and S. Y. Lee, “Development of label-free optical diagnosis for sensitive detection of influenza virus with genetically engineered fusion protein,” Talanta, vol. 89, pp. 246–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. D. Issadore, J. Chung, H. Shao et al., “Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector,” Science Translational Medicine, vol. 4, no. 141, p. 141ra92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. M. S. Kim, T. S. Sim, Y. J. Kim et al., “SSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter,” Lab on a Chip, vol. 12, no. 16, pp. 2874–2880, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Nagrath, L. V. Sequist, S. Maheswaran et al., “Isolation of rare circulating tumour cells in cancer patients by microchip technology,” Nature, vol. 450, no. 7173, pp. 1235–1239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. S. L. Stott, C. Hsu, D. I. Tsukrov et al., “Isolation of circulating tumor cells using a microvortex-generating herringbone-chip,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 43, pp. 18392–18397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. A. H. Talasaz, A. A. Powell, D. E. Huber et al., “Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 10, pp. 3970–3975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. B. J. Kirby, M. Jodari, M. S. Loftus et al., “Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device,” PLoS ONE, vol. 7, no. 4, Article ID e35976, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. H. K. Lin, S. Zheng, A. J. Williams et al., “Portable filter-based microdevice for detection and characterization of circulating tumor cells,” Clinical Cancer Research, vol. 16, no. 20, pp. 5011–5018, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. A. D. Hughes, J. Mattison, L. T. Western, J. D. Powderly, B. T. Greene, and M. R. King, “Microtube device for selectin-mediated capture of viable circulating tumor cells from blood,” Clinical Chemistry, vol. 58, no. 5, pp. 846–853, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. D. Adams, P. Zhu, and O. Makarova, “The systematic study of circulating tumor cell isolation using lithographic microfilters,” RSC Advances, vol. 4, no. 9, pp. 4334–4342, 2014. View at Publisher · View at Google Scholar
  82. T. M. Gorges and K. Pantel, “Circulating tumor cells as therapy-related biomarkers in cancer patients,” Cancer Immunology, Immunotherapy, vol. 62, no. 5, pp. 931–939, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Balic, H. Lin, A. Williams, R. H. Datar, and R. J. Cote, “Progress in circulating tumor cell capture and analysis: implications for cancer management,” Expert Review of Molecular Diagnostics, vol. 12, no. 3, pp. 303–312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Pantel, R. H. Brakenhoff, and B. Brandt, “Detection, clinical relevance and specific biological properties of disseminating tumour cells,” Nature Reviews Cancer, vol. 8, no. 5, pp. 329–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. A. M.C. Barradas and L. W. M. M. Terstappen, “Towards the biological understanding of CTC: capture technologies, definitions and potential to create metastasis,” Cancers, vol. 5, no. 4, pp. 1619–1642, 2013. View at Publisher · View at Google Scholar
  86. G. van Dalum, A. Lenferink, and L. W. M. M. Terstappen, “Detection of EpCAM negative circulating tumor cells in CellSearch waste,” in Proceedings of the 104th Annual Meeting of the American Association for Cancer Research, abstract 3846, Philadelphia, Pa, USA, 2013.
  87. S. de Wit, G. van Dalum, J. van Dalum et al., “Circulating tumor cells in metastatic lung cancer enriched by EpCAM expression and physical characteristics,” in Proceedings of the 105th Annual Meeting of the American Association for Cancer Research, Abstract 4825, San Diego, Calif, USA, April 2014.
  88. F. A. W. Coumans, G. van Dalum, M. Beck, and L. W. M. M. Terstappen, “Filtration parameters influencing circulating tumor cell enrichment from whole blood,” PLoS ONE, vol. 8, no. 4, Article ID e61774, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. G. van Dalum, A. Lenferink, and L. Terstappen, “Detection of EpCAM negative circulating tumor cells in CellSearch waste,” in Proceedings of the 104th Annual Meeting of the American Association for Cancer Research, Washington, DC, USA, 2013.
  90. S. A. Joosse, J. Hannemann, J. Spötter et al., “Changes in keratin expression during metastatic progression of breast cancer: Impact on the detection of circulating tumor cells,” Clinical Cancer Research, vol. 18, no. 4, pp. 993–1003, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. M. G. Krebs, R. L. Metcalf, L. Carter, G. Brady, F. H. Blackhall, and C. Dive, “Molecular analysis of circulating tumour cells—biology and biomarkers,” Nature Reviews Clinical Oncology, vol. 11, no. 3, pp. 129–144, 2014. View at Publisher · View at Google Scholar
  92. T. W. Friedlander, G. Premasekharan, and P. L. Paris, “Looking back, to the future of circulating tumor cells,” Pharmacology & Therapeutics, vol. 142, no. 3, pp. 271–280, 2014. View at Google Scholar
  93. G. Kallergi, M. A. Papadaki, E. Politaki, D. Mavroudis, V. Georgoulias, and S. Agelaki, “Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients,” Breast Cancer Research, vol. 13, no. 3, article R59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. A. J. Armstrong, M. S. Marengo, S. Oltean et al., “Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers,” Molecular Cancer Research, vol. 9, no. 8, pp. 997–1007, 2011. View at Publisher · View at Google Scholar · View at Scopus